Escalon Competitors

OTC Stocks . USA . 
Stock . Escalon Medical Corp
ESMC Stock  USD 0.17  0.00  0.00%   
Escalon Medical Corp competes with Cyduct Diagnostics, and DATATRAK International; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Escalon Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Escalon Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Escalon Medical Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Escalon Medical competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.010.174.83
Details
Intrinsic
Valuation
LowRealHigh
0.010.144.80
Details
Naive
Forecast
LowNextHigh
00.194.85
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.130.160.18
Details

Escalon Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Escalon Medical and its competitors represents the degree of relationship between the price movements of corresponding otcs. A correlation of about +1.0 implies that the price of Escalon and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Escalon Medical Corp does not affect the price movement of the other competitor.

High positive correlations

EVFM
+ 0.47
NSTM
DTRK
+ 0.42
CYDX
EVFM
+ 0.37
CYDX
BMMJ
+ 0.37
NSTM
MJNA
+ 0.35
CYDX
BINP
+ 0.25
MJNA
  

High negative correlations

NSTM
- 0.37
TBIO
DTRK
- 0.33
TBIO
BINP
- 0.3
BMMJ
MJNA
- 0.25
BMMJ
BMMJ
- 0.23
CYDX
BMMJ
- 0.22
TBIO

Risk-Adjusted Indicators

There is a big difference between Escalon OTC Stock performing well and Escalon Medical OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Escalon Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
CYDX  2.42  0.41  0.00 (0.15) 0.00 
 0.00 
 0.00 
 0.00 
 108.91 
CHYPF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
TBIO  50.34  21.13  0.40  0.79  15.86 
(253.92)
 75.00 
(8.33)
 786.15 
NSTM  4.53  0.27  0.00 (0.13) 0.00 
 0.00 
 0.00 
 0.00 
 100.00 
BMMJ  16.72  1.45  0.06 (0.57) 19.48 
(17.97)
 48.57 
(32.31)
 121.50 
CTVEF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
MJNA  28.37  8.16  0.18 (0.96) 21.29 
(70.00)
 100.00 
(50.00)
 266.67 
BINP  13.64  3.36  0.10  11.83  14.40 
(29.50)
 35.00 
(36.36)
 176.17 
DTRK  6.55 (0.64) 0.00 (0.09) 0.00 
 0.00 
 17.00 
(17.65)
 91.18 
EVFM  6.90  0.00  0.00  0.08  7.29 
(13.51)
 20.00 
(15.38)
 50.00 
All Fundamental Data

Escalon Medical Competitive Analysis

The better you understand Escalon Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Escalon Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Escalon Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ESMC CYDX TBIO NSTM BMMJ CTVEF MJNA BINP DTRK EVFM
 0.00 
 0.17 
Escalon
 0.00 
 0.20 
Cyduct
 78.69 
 0.01 
Telesis
 55.00 
 0.01 
Hollywood
 13.33 
 0.01 
Body
 0.00 
 0 
Certive
 33.33 
 0.0002 
Medical
 93.55 
 0.03 
Bionoid
 8.57 
 0.38 
DATATRAK
 17.27 
 0.01 
Evofem
Market Volatility
(90 Days Market Risk)
Out of control
Out of control
Out of control
Out of control
Very steady
Very steady
Out of control
Out of control
Out of control
Out of control
Market Performance
(90 Days Performance)
Good
Weak
Good
Weakest
Weakest
Weakest
Good
Fair
Weakest
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Strong
High
High
Low
Hazard
Risky
Low
Moderate
Risky
Risky
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Not Rated
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
1.39
1.78
5.93
1.06
1.26
0.08
1.92
0.07
3.33
0.16
Net Asset
5.17 M
N/A
70.41 M
N/A
31.03 M
748.49 K
N/A
N/A
N/A
42.51 M
Profit Margin
-0.0583
0.4
-2.53
N/A
-0.97
-2.13
0.15
N/A
-0.0011
N/A
EBITDA
84.92 K
(502.35 K)
(31.05 M)
(4.81 M)
(21.51 M)
(1.51 M)
1.45 M
(385.71 K)
(971.95 K)
(204.14 M)
Operating Margin
-0.0566
-1.49
-6.76
N/A
-0.18
-1.75
-0.0376
-4.22
-0.15
-5.41
Current Valuation
2.07 M
404.62 K
61.1 M
7.86 M
18.77 M
11.55 M
62.53 M
3.81 M
9.95 M
112.69 M
Price To Book
1.12
N/A
1.11
0.51
0.32
N/A
0.55
N/A
N/A
8.37
Retained Earnings
(66.22 M)
N/A
(161.47 M)
N/A
N/A
(21.81 M)
31.14 M
N/A
(30.86 M)
(526.68 M)
Current Asset
4.13 M
N/A
3.28 M
N/A
N/A
1.73 M
14.02 M
N/A
2.19 M
16.39 M
Beta
-0.39
-0.42
1.76
0.51
2.42
0.61
1.12
-2.12
1.2
-1.25
Number Of Employees
41
3
101
8
128
7
91
5
11
119
Shares Outstanding
7.42 M
N/A
1.77 M
46.88 M
146.64 M
160.58 M
3.44 B
42.28 M
1.51 M
121.22 M
Cash Flow From Operations
(1.05 M)
(53.6 K)
(34.67 M)
(180.93 K)
(3.44 M)
(1.25 M)
86.86 M
(357.62 K)
(2.21 M)
(146.67 M)
Total Debt
153.43 K
171.98 K
34.38 M
100 K
7.39 M
243.06 K
10.41 M
64.5 K
1.3 M
125.74 M
Return On Equity
-0.42
0.0839
-1.48
0.23
-1.47
N/A
0.12
N/A
-0.005
-3.87
Z Score
-13.6
1.2
N/A
55.8
1.6
-42.0
3.0
N/A
-6.6
-30.0
Return On Asset
-0.0724
-0.14
-0.27
-0.11
-0.0932
-2.24
-0.0146
-1.64
-0.08
-1.25
Number Of Shares Shorted
2.01 K
N/A
29.7 K
5.34 K
N/A
N/A
N/A
N/A
309
8.68 M
Book Value Per Share
0.069
6.35
-11.59
0.037
0.058
-0.062
0.02
-29.92
0.61
-0.76
Current Liabilities
2.78 M
N/A
16.98 M
N/A
N/A
6.63 M
5.37 M
N/A
3.37 M
12.61 M
Total Asset
5.17 M
N/A
70.41 M
N/A
31.03 M
748.49 K
209.53 M
N/A
3.83 M
42.51 M
Debt To Equity
0.82
0.088
0.16
0.051
0.44
81.8
0.13
N/A
0.88
8.72
Short Ratio
0.31
N/A
0.42
0.12
N/A
N/A
N/A
N/A
0.1
0.19
Target Price
7.0
N/A
4.0
2.5
N/A
N/A
N/A
N/A
8.0
2.9
Shares Owned By Institutions
N/A
N/A
32.97
0.05
12.03
N/A
N/A
N/A
76.04
0.57
Market Capitalization
404.06 K
349.68 K
5.73 M
9.33 M
10.63 M
4.82 M
56.49 M
42.28 M
8.42 M
6.41 M
Price To Earning
4.5
0.52
71.32
0.64
N/A
-0.26
5.25
N/A
134.62
-1.26
Price To Sales
0.0453
1.12
0.29
32.16
0.27
4.86
0.86
540.76
1.87
0.42
Net Income
18.08 K
(503.79 K)
(47.72 M)
(481.07 K)
(28.68 M)
(2.48 M)
84.4 M
(1.62 M)
(90.19 K)
(205.19 M)
Earnings Per Share
0.02
0.77
-30.42
0.17
-0.036
-0.015
0.002
-46.27
-0.009
-19.01
Shares Owned By Insiders
1.9
N/A
37.9
N/A
1.2
12.54
N/A
N/A
N/A
0.28
Revenue
10.7 M
344.78 K
27.51 M
424.75 K
31.64 M
1.2 M
58.98 M
92.26 K
6.5 M
8.24 M
Working Capital
1.36 M
N/A
22.17 M
N/A
N/A
(4.9 M)
8.65 M
N/A
(1.18 M)
3.78 M
Cash And Equivalents
593.87 K
13.33 K
654.75 M
79.14 K
3.71 M
33.34 K
4.68 M
127
1.83 M
19.89 M
Cash Per Share
0.08
0.04
8.7
N/A
0.03
N/A
N/A
N/A
0.76
0.23
Gross Profit
4.61 M
193.76 K
15.6 M
(1.63 M)
6.32 M
(205.57 K)
57.73 M
47.48 K
5.23 M
4.19 M
Day Typical Price
0.17
0.2
0.013
0.0101
0.0082
0.0016
2.0E-4
0.03
0.4
0.0094
Accumulation Distribution
N/A
N/A
N/A
84904.39
0.13
N/A
N/A
N/A
805.0
548.1
Market Facilitation Index
N/A
N/A
N/A
N/A
0.0012
N/A
N/A
N/A
0.0
N/A
Daily Balance Of Power
0.0
0.0
(9,223,372,036,855)
(3.44)
(1.00)
0.0
(9,223,372,036,855)
9.2 T
0.4286
(1.90)
Period Momentum Indicator
N/A
N/A
(0.05)
(0.01)
(0)
N/A
(0.0001)
0.0145
0.03
(0)
Rate Of Daily Change
1.0
1.0
0.21
0.45
0.87
1.0
0.67
1.94
1.09
0.83
Day Median Price
0.17
0.2
0.013
0.0106
0.0084
0.0016
2.0E-4
0.03
0.42
0.0095
Price Action Indicator
N/A
N/A
(0.02)
(0.01)
(0)
N/A
(0.00005)
0.0073
(0.02)
(0)
Relative Strength Index
27.1
41.46
55.98
N/A
45.26
N/A
53.46
59.26
26.55
56.28
Coefficient Of Variation
(1,172)
3602.06
534.98
9706.08
1836.82
N/A
559.47
748.75
(4,105)
8583.46
Mean Deviation
3.9
2.42
50.34
4.53
16.72
N/A
28.37
13.64
6.55
6.9
Jensen Alpha
(0.73)
0.4073
21.13
0.2652
1.45
N/A
8.16
3.36
(0.64)
0.0049
Total Risk Alpha
(1.57)
(0.81)
9.94
(1.67)
(1.26)
N/A
3.02
0.6591
(1.81)
(0.98)
Sortino Ratio
N/A
N/A
0.4037
N/A
0.0561
N/A
0.1779
0.101
N/A
0.0029
Downside Variance
N/A
N/A
3320.38
N/A
459.37
N/A
1773.5
1073.66
N/A
127.87
Standard Deviation
8.1
10.1
124.92
17.16
23.63
N/A
42.38
25.42
13.68
10.13
Kurtosis
13.44
29.59
24.09
20.67
1.62
N/A
5.83
9.37
6.31
1.63
Potential Upside
7.14
N/A
75.0
N/A
48.57
N/A
100.0
35.0
17.0
20.0
Treynor Ratio
(1.62)
(0.15)
0.7939
(0.13)
(0.57)
N/A
(0.96)
11.83
(0.09)
0.0788
Maximum Drawdown
43.33
108.91
786.15
100.0
121.5
N/A
266.67
176.17
91.18
50.0
Variance
65.66
101.93
15604.41
294.37
558.56
N/A
1796.43
646.27
187.12
102.61
Market Risk Adjusted Performance
(1.61)
(0.14)
0.8039
(0.12)
(0.56)
N/A
(0.95)
11.84
(0.08)
0.0888
Risk Adjusted Performance
(0.05)
0.0288
0.1411
0.0168
0.0479
N/A
0.1352
0.1034
(0.01)
0.0175
Skewness
(2.80)
2.29
4.85
2.47
0.826
N/A
1.8
1.96
1.3
0.9225
Semi Deviation
N/A
N/A
15.86
N/A
19.48
N/A
21.29
14.4
N/A
7.29
Information Ratio
(0.1)
0.0193
0.1862
0.0053
0.0508
N/A
0.1767
0.1302
(0.03)
0.0032
Value At Risk
(12.50)
N/A
(8.33)
N/A
(32.31)
N/A
(50.00)
(36.36)
(17.65)
(15.38)
Expected Short fall
N/A
N/A
(253.92)
N/A
(17.97)
N/A
(70.00)
(29.50)
N/A
(13.51)
Downside Deviation
N/A
N/A
57.62
N/A
21.43
N/A
42.11
32.77
N/A
11.31
Semi Variance
N/A
N/A
251.51
N/A
379.38
N/A
453.38
207.23
N/A
53.16

Escalon Medical Competition Performance Charts

Five steps to successful analysis of Escalon Medical Competition

Escalon Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Escalon Medical Corp in relation to its competition. Escalon Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Escalon Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Escalon Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Escalon Medical Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Escalon Medical position

In addition to having Escalon Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aluminum Thematic Idea Now

Aluminum
Aluminum Theme
Companies involved in production of aluminum. The Aluminum theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aluminum Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Escalon OTC Stock

Escalon Medical financial ratios help investors to determine whether Escalon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Escalon with respect to the benefits of owning Escalon Medical security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY